Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Understanding the impact of SARS-CoV-2 by studying similar viruses

Resistance against the deadly "Take all" plant disease!

Prader-Willi Syndrome Awareness month, 2021

Understanding the impact of SARS-CoV-2 by studying similar viruses
  • BiotechToday
  • World

Understanding the impact of SARS-CoV-2 by studying similar viruses

bioxone May 19, 2021May 19, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata

Just a few months after the Covid-19 pandemic began, scientists were able to sequence the full genome of the SARS-CoV-2virus that had caused the infection. Most of its genes were already known then but the full complement of protein-coding genes remained unresolved. After performing an extensive comparative study, researchers have developed the most accurate and complete gene annotation of the SARS-CoV-2 virus. They also confirmed the presence of several protein-coding genes and also came across a few others that were thought to be genes but they were found to not code for any proteins. The scientists used a comparative genomics approach to discover and know about the functional protein-coding content of the genes. About 2,000 mutations have been seen in different SARS-CoV-2 isolates since it began infecting humans, or rather since the pandemic. These required research to observe the changing the virus’s ability to evade the immune system and become more infectious. 

Comparative genomics involves identifying several regions that are known to encode protein-coding genes. This is done based on their similarity to protein-coding genes found in similar related viruses. The researchers compared the genome of similar viruses to understand which part of the virus, SARS-CoV-2 contained genes. The virus is known to belong to a subgenus of viruses commonly known as Sarbecovirus. These are known to mostly infect bats. The researchers performed their comparative analysis by comparing SARS-CoV-2, SARS-CoV (caused the 2003 SARS outbreak), and other 42 strains of bat sarbecoviruses. The method is based on analyzing whether certain DNA or RNA bases are conserved between species, and thereby comparing their patterns of evolution over time.

Alongside the five protein-coding genes that common in all viruses, SARS-CoV-2 also shows the presence of six other protein-coding genes. It was observed that the region encoding a gene called ORF3a also encodes an additional gene- ORF3c. It consists of RNA bases that overlap with ORF3a but it occurs in a different reading frame. This type of “gene-within-a-gene” is quite rarely seen in large genomes but is commonly seen in many viruses, whose genomes are under selective pressure to stay compact. The role of this new gene is not known yet. Five other regions that were proposed as possible genes were shown to not encode any functional proteins. And the scientists ruled out the possibility of such genes that are yet to be discovered. 

Again, the researchers studied all the 2000 mutations that have arisen in the SARS-CoV-2  since the pandemic. For each gene, they compared how much that specific gene has evolved in the past vs how much it has evolved since the start of the pandemic. They identified a region of the nucleocapsid protein that surrounded the viral genetic material. It had more mutations than was expected of it by observing its history. The most mutation-prone region in the entire genome of the virus lies in the middle of this nucleocapsid protein. 

It was discovered that the variants that lack mutations in that region got recognized by the human immune system while those variants that randomly mutate in that region were able to evade the immune system and survive for a longer period. The evolutionary context of these mutant variants needs to be studied to understand how the current pandemic fits in the history of virology.

Also read:DRDO’s “2-DG” Anti-Covid Drug has been finally launched

References: Jungreis, I., Sealfon, R. & Kellis, M. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. Nat Commun 12, 2642 (2021). https://doi.org/10.1038/s41467-021-22905-7

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Evolution genome genomics mutant Mutation nucleocapsid pandemic Sarbecovirus SARS-CoV-2 virus

One thought on “Understanding the impact of SARS-CoV-2 by studying similar viruses”

  1. Pingback: Prader-Willi Syndrome Awareness month, 2021 - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Prader-Willi Syndrome Awareness month, 2021

bioxone May 19, 2021

Camelia Bhattacharyya, Amity University Kolkata Marie Curie once said, “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more so that we can fearless.” So why fear any underdevelopment in our body that has already been explained and is studied highly for a proper diagnosis […]

Prader-Willi Syndrome

Related Post

  • BiotechToday
  • World

Studies Showing Connections Between Gut Microbiome And Brain: The Gut-Brain Axis

bioxone October 6, 2020October 5, 2020

SHRESTHA DUTTA, AMITY UNIVERSITY KOLKATA Studies show that the ageing cycle might be connected with age-related changes in our gut microbiota. Currently, the presence of two-way communication between the gut and the mind – known as the ‘gut-brain axis – has played a significant role in moulding the aspects of behaviour and cognitive function. Researches […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Scientists develop Novel Cholera Vaccine from Rice Grains

BioTech Today June 29, 2021June 28, 2021

Agrima Bhatt, Rajasthan University What is Cholera? Cholera is a diarrheal sickness caused by the toxigenic bacterium Vibrio cholerae infecting the intestine. Each year, an estimated 2.9 million cases and 95,000 deaths occur in the population worldwide. The World Health Organization estimates that 1.3 million to 4 million people are infected with cholera each year, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

bioxone March 4, 2021March 4, 2021

Devyani Goswami, Amity University Kolkata Nanette Cocero, global president, vaccines, of Pfizer announced that their tick-borne encephalitis vaccine (TBE) has been approved for a priority review from the US Food and Drug Administration (FDA).  Once approved the vaccine promises to cure tick-borne encephalitis epidemics all across the US. The vaccine has to be subjected twice […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy